Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies - Stokowski, R; Wang, E; White, K (Prenatal diagnosis, 2015)
et al.